Protein and Nucleic Acid Quality Evaluation Device 'STUNNER'

The development of lipid nanoparticles (LNP) requires flexible tools that can accommodate everything from screening to GMP manufacturing. The ideal manufacturing equipment should be capable of handling a wide range of applications, from small-scale, easy-to-handle experiments to multi-parameter, multi-sample, large-scale continuous operations. Additionally, not only is the production of LNP important, but the evaluation of characteristics such as encapsulation efficiency (EE%), RNA amount, particle size, and PDI is also crucial; traditionally, these measurements have been complicated and required multiple instruments. In this webinar, we will introduce scalable LNP manufacturing by Sunshine and one-stop measurements of EE%, total RNA, particle size, PDI, and particle concentration using Stunner AF. Furthermore, you will also be able to watch a demo video showcasing the actual operation of the Sun series (Sunshine, Sunscreen) and Stunner! Instructor: Takuma Iwasaki | Field Application Scientist *This webinar is a recording of a session hosted by Unchained Labs, Inc. in October 2025.

Unchained Labs, Inc. will be exhibiting at the 4th Annual Meeting of the Japanese Society for Antibody Research, which will be held from December 1 (Monday). At our booth, we will introduce innovative tools essential for antibody and ADC research, such as Aunty, a device for evaluating protein structural stability, and Stunner, which can measure various parameters including potency and size. We look forward to seeing you in Omiya! Exhibition details: ■ Dates: December 1 (Monday) to 3 (Wednesday), 2025 ■ Venue: Omiya Sonic City

The analysis of antibodies and antibody-drug conjugates (ADCs) is no longer a headache. Stunner measures the concentration, size, and aggregation of antibodies using just 2 µL of sample in 2 minutes, processing up to 96 samples in a single run. In this webinar, we will detail how Stunner's Unmix software separates the signals of antibodies and drugs, allowing for the rapid quantification of protein amount, drug amount, and drug-antibody ratio (DAR). Be sure to see how Stunner streamlines the cumbersome ADC characterization process.

The development of lipid nanoparticles (LNPs) requires flexible tools that can consistently handle everything from screening to GMP manufacturing. An ideal manufacturing tool must accommodate small-scale, user-friendly experiments as well as multi-parameter, multi-sample, and even large-scale continuous operations. However, the creation of lipid nanoparticles (LNPs) is only half the goal; evaluating characteristics such as encapsulation efficiency (EE%), payload quantification, particle size, and PDI is also essential. Our Sunshine series and Stunner AF (Add Fluorescence) enable scalable nanoparticle manufacturing and powerful all-in-one characterization. In this webinar, we will introduce scalable LNP manufacturing with Sunshine and one-stop measurements of EE%, total RNA quantification, particle size, PDI, and particle concentration with Stunner AF. Experience solutions that will take nanoparticle development to the next level, from research to industrial applications.